v3.6.0.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended
Jan. 31, 2017
Jan. 31, 2016
Revenue
Operating costs and expenses:    
Litigation and licensing expense 2,121 59,641
Amortization of patents 81,324 81,324
Research and development expenses (including non-cash stock option compensation expenses of $79,700 and $18,946, respectively) 451,630 458,051
Marketing, general and administrative expenses (including non-cash stock option compensation expenses of $180,037 and $93,549, respectively) 859,885 873,423
Total operating costs and expenses 1,394,960 1,472,439
Loss from operations (1,394,960) (1,472,439)
Interest expense (Notes 6 and 10) (195,299) (123,901)
Interest income 999 3,251
Loss before income taxes (1,589,260) (1,593,089)
Provision for income taxes
Net loss (1,589,260) (1,593,089)
Deemed dividend to preferred stockholder (Note 6) (2,008,775)  
Net loss attributable to common stockholders $ (3,598,035) $ (1,593,089)
Net loss per common share:    
Basic and diluted (in Dollars per share) $ (0.41) $ (0.18)
Weighted average common shares outstanding:    
Basic and diluted (in Shares) 8,755,057 8,727,035

Source